1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmo, Sweden
(
- Contribution to journal › Article
- 2006
-
Mark
Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis
(
- Contribution to journal › Article
- 2004
-
Mark
The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia.
(
- Contribution to journal › Article
-
Mark
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of infliximab (Remicade((R))) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study.
(
- Contribution to journal › Article
- 2002
-
Mark
Modeling the progression of rheumatoid arthritis - A two-country model to estimate costs and consequences of rheumatoid arthritis
(
- Contribution to journal › Article